NeuPath Health Inc's stock has seen a slight decline over the week, reflecting broader trends in the health care sector.
This week, NeuPath Health Inc (NPTH.V) closed at C$0.54, unchanged from the previous day but down 3.57% over the past week. The company has had a challenging month, with a 15.63% drop in value. Amidst this, recent financial results and leadership changes have generated some discussion among investors.
Advertisement
NeuPath Health Inc
NPTH.V
NPTH.V
NeuPath Health Inc
WealthAwesomeMarket cap
$30.77M
P/E
27.0x
52W high
$0.68
52W low
$0.28
1W change
-3.57%
Beta
1.04
Analyst Price Targets
Based on analyst covering NPTH
Wall Street analysts forecast NPTH stock price to rise 41.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.77
+41.7% Upside
Current Price
C$0.54
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NPTH's historical volatility
30-Day Vol
36.2%
Annualized
90-Day Vol
49.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.45
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.51 | C$0.45 โ C$0.58 |
| 60 trading days | C$0.48 | C$0.40 โ C$0.57 |
| 90 trading days | C$0.45 | C$0.36 โ C$0.56 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: NeuPath Health's recent financial performance, including a year-over-year revenue increase, indicates potential growth, but the stock's recent underperformance may warrant caution for investors looking at short-term gains.
NeuPath Health's Revenue Grows 17% Year-Over-Year
The company's total revenue reached $22.1 million for the year ending December 31, 2025, reflecting a strong growth trend in its financial performance.
Bull case
The company recently reported a significant revenue increase, suggesting a positive outlook for future earnings. The new CEO's leadership could bring fresh strategies that enhance growth.
Bear case
Despite the revenue growth, the stock has struggled in the short term, experiencing a notable decline over the past month. Investors may be concerned about whether this growth can be sustained in a competitive market.
Price Action Overview
NeuPath Health Inc's stock closed at C$0.54, marking a 0.00% change for the day. Over the past week, the stock has declined by 3.57%, and it has dropped 15.63% in the last month. Year-to-date, the stock is up 3.85%, indicating some resilience despite recent fluctuations.
Advertisement
Recent Company News
NeuPath Health has reported its financial results for Q4 and the year ending December 31, 2025, showcasing a 17% increase in total revenue to $22.1 million. Additionally, the company announced an upcoming CEO transition, with Stephen Lemieux set to succeed Joseph Walewicz on April 1, 2026. This leadership change may influence the company's strategic direction moving forward.
Technical Picture
From a technical perspective, NeuPath Health's stock is currently trading below its 50-day moving average of C$0.60, indicating a bearish short-term trend. However, it is at the low end of its 52-week range of C$0.28 to C$0.68, suggesting potential for recovery. The stock has a beta of 1.04, indicating it moves in line with market volatility, and the current volume of 3,810 shares is significantly lower than the 20-day average volume of 50,190 shares, reflecting reduced trading activity.
Insider Activity
There are no reported insider transactions for NeuPath Health Inc at this time, suggesting that insiders may not be actively buying or selling shares, which could indicate confidence in the company's current strategy.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
